AMT
55
-3
AVY
62
8
IRM
68
-3
PFG
59
6
CAG
36
-3
LB
45
4
MU
31
4
PCAR
53
5
AME
59
5
CTAS
58
2
AMG
44
3
ADM
36
6
CAT
69
7
MRK
50
-3
HST
57
5
HON
59
4
MCD
65
2
MOS
23
3
XYL
58
6
ROST
62
2
AMT
55
-3
AVY
62
8
IRM
68
-3
PFG
59
6
CAG
36
-3
LB
45
4
MU
31
4
PCAR
53
5
AME
59
5
CTAS
58
2
AMG
44
3
ADM
36
6
CAT
69
7
MRK
50
-3
HST
57
5
HON
59
4
MCD
65
2
MOS
23
3
XYL
58
6
ROST
62
2
Financhill
Back

LENZ Therapeutics Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
3

LENZ
LENZ Therapeutics

Last Price:
22.20
Seasonality Move:
-17.69%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

LENZ Therapeutics Price Quote

$22.20
+0.14 (+0.63%)
(Updated: September 20, 2024 at 2:45 PM ET)

LENZ Therapeutics Key Stats

Sell
3
LENZ Therapeutics (LENZ) is a Sell
Day range:
$21.31 - $22.60
52-week range:
$14.07 - $29.82
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.14%
Volume:
82.7K
Avg. volume:
136.3K
1-year change:
28.63%
Market cap:
$606M
Revenue:
$15M
EPS:
$-5.6

How Much Does LENZ Therapeutics Make?

Data Unavailable

Is LENZ Therapeutics Growing As A Company?

Data Unavailable

LENZ Therapeutics Stock Price Performance

What Is LENZ Therapeutics 52-Week High & Low?

LENZ Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy LENZ Therapeutics?

  • How Much Debt Does LENZ Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does LENZ Therapeutics Have?
    Cash and short term investments quarterly total is $196.1M
  • What Is LENZ Therapeutics’s Book Value Per Share?
    Book value per share is 7.46

Is LENZ Therapeutics Cash Flow Positive?

  • What Is LENZ Cash Flow From Operations?
    Cash flow from operations (TTM) is -$73.8M
  • What Is LENZ Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $166.7M
  • What Is LENZ Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$83.1M

LENZ Therapeutics Return On Invested Capital

Data Unavailable

LENZ Therapeutics Earnings Date & Stock Price

LENZ Therapeutics Competitors

  • Who Are LENZ Therapeutics's Competitors?
    Below is a list of companies who compete with LENZ Therapeutics or are related in some way:
    • Oruka Therapeutics Inc (ORKA)
    • PetMed Express Inc (PETS)
    • R1 RCM Inc (RCM)
    • Streamline Health Solutions Inc (STRM)
    • TruBridge Inc (TBRG)

LENZ Therapeutics Dividend Yield

LENZ Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 40.3%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 35.33
Upside from Last Price: 60.17%

Major Shareholders

  • How many LENZ shares are owned by institutional investors?
    29.2M LENZ shares are owned by institutional investors
  • How many LENZ shares are owned by insiders?
    242.8K LENZ shares are owned by insiders